Miromatrix Medical OverviewMiromatrix Medical's EBIT is $-28M, below the Healthcare sector average of $22B.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023
As of the most recent data (September 2023), MIRO shows a EBIT of $-28M. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.
The Healthcare sector average EBIT is about $22B. Miromatrix Medical is at $-28M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how MIRO stacks up against individual peers as well.
Tracking MIRO's ebit over time shows whether Miromatrix Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $-28M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Miromatrix Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-28M) with ownership activity and broader fundamentals.
The Healthcare average EBIT is about $22B, while MIRO is at $-28M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
